Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are an adult (18 or older) receiving treatment in a nuclear medicine department and have been approved by a pharmacist for your first Targeted Radionuclide Therapy (a type of treatment that uses radioactive substances to target cancer cells).
- You are a patient for whom a pharmacist has stepped in to review or adjust your treatment, whether this is your first or a later round of Targeted Radionuclide Therapy.
Who may not be able to join:
- You are under 18 years of age.
- You are a patient who did not have any pharmacist involvement in your care, unless this applies to your very first round of Targeted Radionuclide Therapy (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: + 33 (0)4 27 85 54 14
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate the contribution of conducting a medication reconciliation to improve the safety of the care pathway for patients receiving their first Targeted Radiotherapy (initial course), compared to care without medication reconciliation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.